| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.7M | — | -7.1% |
| Cost of Revenue | $1.6M | — | +4.8% |
| Gross Profit | $8.1M | — | -9.1% |
| R&D Expense | $3.9M | — | -34.7% |
| SG&A Expense | $6.0M | — | -30.0% |
| Operating Income | -$6.2M | — | +49.7% |
| Pre-tax Income | -$4.8M | — | +53.7% |
| Net Income | -$4.8M | — | +53.7% |
| EPS (Basic) | -$0.04 | — | +60.0% |
| EPS (Diluted) | -$0.04 | — | +60.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.6M | -27.5% | -37.8% |
| Short-term Investments | $92.3M | +11.2% | -19.7% |
| Accounts Receivable | $4.2M | +21.2% | -23.1% |
| Inventory | $7.6M | +1.1% | -7.8% |
| Current Assets | $122.9M | +3.9% | -21.1% |
| Total Assets | $194.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.2M | — | +43.3% |
| Capital Expenditures | $72K | — | -89.0% |
| Investing Cash Flow | $2.7M | — | -72.1% |
| Financing Cash Flow | $5K | — | -98.7% |
| Free Cash Flow | -$8.2M | — | +45.3% |
| -15.4% |
| Current Liabilities | $10.2M | -28.4% | -19.8% |
| Total Liabilities | $26.6M | -14.3% | -13.0% |
| Stockholders' Equity | $167.9M | -2.1% | -15.8% |